Iridex Corp (NASDAQ:IRIX) Reports Mixed Q3 2025 Results, Stock Falls Over 13% on Earnings Misschartmill.comIridex (IRIX) reported mixed Q3 2025 results, missing revenue and EPS estimates. The stock fell over 13% despite highlighting operational improvements and cost reductions.
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024investorplace.comIRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024investorplace.comIRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023investorplace.comIRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Earnings Scheduled For March 26, 2024benzinga.comCompanies Reporting Before The Bell • bluebird bio (
NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
